Clinical Trial

Comparison of Remimazolam and Propofol in Endoscopic Examinations and Treatments

Study acronym: Remimazolam
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This study aims to evaluate the efficacy and safety of Remimazolam, either used alone or in combination with Propofol, for moderate sedation anesthesia during endoscopic therapies or examinations. Additionally, it seeks to explore whether their combination can further enhance the quality of patient anesthesia and recovery outcomes.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-01-15.
Trial Details
NCT Number NCT06777758
Lead Sponsor Kaohsiung Veterans General Hospital.
Conditions Postoperative Complications, Respiratory Depression, Postoperative Nausea, Vomiting, Constipation
Enrollment 90 participants
Start Date 2025-02-12
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-08